About iuvo

iuvo Therapeutics is a pharmaceutical company founded in 2017 and headquartered in Düsseldorf. iuvo’s goal is the reliable supply of high-quality cannabis-based medicines to patients within Europe. iuvo is an independent importer, manufacturer, and wholesaler, constantly expanding its supply chain focusing on established GMP- and GDP-compliant partners. The distribution of our products takes places directly to pharmacies as well as through selected pharmaceutical wholesalers.
iuvo develops its pharmaceuticals based on the latest scientific knowledge. In cooperation with experts in cannabis therapy, the company supports doctors and pharmaceutical specialists through recognized scientific training courses. 
iuvo Therapeutics is also an active member of the Federal Association of Pharmaceutical Cannabinoid Companies.

Press

Alexander Rieg Takes Over as Managing Director of iuvo

03.01.2022
Alexander Rieg took over the position of Daniel Seidl as Managing Director at iuvo Therapeutics at the turn of the year.

iuvo Organizes Practice-relevant Online Training with Prof. Dr. Karst about Medical Cannabis

05.11.2021
Potsdam/ Hanover, November 5, 2021 – In collaboration with Prof. Dr. Matthias Karst from the Hannover Medical School (MHH) iuvo Therapeutics GmbH (iuvo Therapeutics or iuvo) is organizing a practice-relevant online training course for doctors on cannabis‑based medicine (CBM) on November 17, 2021. The advanced training course “Insights into an efficient therapy with cannabis-based pharmaceuticals”, […]

iuvo Expands Sales Network with Established Partner Cansativa

04.11.2021
Düsseldorf / Frankfurt am Main, November 4, 2021 – iuvo Therapeutics GmbH (iuvo Therapeutics or iuvo) is expanding its sales network: Cansativa GmbH (Cansativa) now offers iuvo’s high-quality full-spectrum cannabis extracts. iuvo Therapeutics and Cansativa have entered into a strategic distribution partnership. The well-established wholesaler with a focus on cannabis-based pharmaceuticals has expanded its product […]

iuvo Strengthens Management Team with Experienced Industry Pioneer, Alexander Rieg

20.10.2021
Düsseldorf, October 2021 – iuvo Therapeutics GmbH is proud to announce Alexander Rieg has joined the management team as of October 2021. With his extensive experience in the sales and marketing of pharmaceuticals in Germany, Alexander Rieg founded and acted as managing director of GECA Pharma GmbH. One of the first fully licensed importers of […]

Wholesale

We offer selected pharmaceutical wholesalers certified cannabinoid-based medicine.

GMP Without Compromises

All products are manufactured from GMP compliant starting material through our accredited and qualified manufacturing partners. iuvo is providing an EU market release through its QP and is performing ongoing quality control.

Unmatched Quality and Purity

Due to meticulous in-process-control as well as the end to end monitored supply chain, no irradiation is needed to uphold quality standards. Analytics are exclusively performed by experienced GMP certified labs and redundant quality control procedures are ensuring ongoing patient safety.

Fully Validated Rapid ID Test Kits for Pharmacies

With the help of the test kits, the identity of THC and CBD can be checked faster and cheaper in the pharmacy. They have been validated by a leading German laboratory as an alternative to the DAB monograph “Standardized cannabis extract”.

White Label Production

We offer white label solutions including labeling at manufacture.

For wholesale enquiries:
+49 331 769 92 0
wholesale@iuvo-therapeutics.com

Contact

    Informationen zur Verwendung Ihrer Daten finden Sie in unserer Datenschutzerklärung.

    array(0) { }